Sale!

COL1A1 Gene Ehlers-Danlos Syndrome Type 7A Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The COL1A1 Gene Ehlers-Danlos Syndrome Type 7A Genetic Test is a specialized diagnostic tool designed to identify mutations in the COL1A1 gene, which are associated with Ehlers-Danlos Syndrome Type 7A (EDS Type 7A). This condition is a rare variant of the Ehlers-Danlos Syndromes, a group of genetic disorders that affect the connective tissues supporting the skin, bones, blood vessels, and many other organs and tissues. Mutations in the COL1A1 gene can lead to defects in the production of type I collagen, a critical component of connective tissues, resulting in symptoms such as hypermobility of joints, skin hyperextensibility, and tissue fragility.

The test, priced at 4400 AED, is conducted at DNA Labs UAE, a state-of-the-art facility known for its comprehensive genetic testing services. Through a simple blood sample or other tissue samples, DNA Labs UAE can accurately analyze the COL1A1 gene for any mutations. The results from this test can provide crucial information for the diagnosis, treatment planning, and management of Ehlers-Danlos Syndrome Type 7A, helping affected individuals and their families understand their condition better and make informed health decisions.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

COL1A1 Gene Ehlers-Danlos syndrome type 7A Genetic Test

Components:

  • Price: 4400.0 AED
  • Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
  • Report Delivery: 3 to 4 Weeks
  • Method: NGS Technology
  • Test type: Osteology Dermatology Immunology Disorders
  • Doctor: Dermatologist
  • Test Department: Genetics

Pre Test Information:

Clinical History of Patient who is going for COL1A1 Gene Ehlers-Danlos syndrome type 7A NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with COL1A1 Gene Ehlers-Danlos syndrome type 7A NGS Genetic DNA Test gene COL1A1.

Test Details:

The COL1A1 gene is responsible for producing a protein called type I collagen, which is a major component of connective tissues in the body. Mutations in this gene can lead to a condition called Ehlers-Danlos syndrome type 7A. Ehlers-Danlos syndrome is a group of genetic disorders that affect the connective tissues, causing them to be weak and easily damaged. Type 7A is a specific subtype of Ehlers-Danlos syndrome that is characterized by joint hypermobility, skin hyperextensibility, and tissue fragility. It can also affect other organs and systems in the body, leading to various complications.

NGS (Next-Generation Sequencing) genetic testing is a type of genetic test that uses advanced sequencing technology to analyze multiple genes simultaneously. In the case of Ehlers-Danlos syndrome type 7A, NGS genetic testing can be used to identify mutations or variations in the COL1A1 gene that may be responsible for the condition. By identifying these genetic changes, NGS testing can help confirm a diagnosis of Ehlers-Danlos syndrome type 7A and provide important information for genetic counseling, treatment planning, and management of the condition. It can also be used for carrier testing and prenatal diagnosis in families with a known COL1A1 gene mutation.

Test Name COL1A1 Gene Ehlers-Danlos syndrome type 7A Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Osteology Dermatology Immunology Disorders
Doctor Dermatologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for COL1A1 Gene Ehlers-Danlos syndrome type 7A NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with COL1A1 Gene Ehlers-Danlos syndrome type 7A NGS Genetic DNA Test gene COL1A1
Test Details

The COL1A1 gene is responsible for producing a protein called type I collagen, which is a major component of connective tissues in the body. Mutations in this gene can lead to a condition called Ehlers-Danlos syndrome type 7A.

Ehlers-Danlos syndrome is a group of genetic disorders that affect the connective tissues, causing them to be weak and easily damaged. Type 7A is a specific subtype of Ehlers-Danlos syndrome that is characterized by joint hypermobility, skin hyperextensibility, and tissue fragility. It can also affect other organs and systems in the body, leading to various complications.

NGS (Next-Generation Sequencing) genetic testing is a type of genetic test that uses advanced sequencing technology to analyze multiple genes simultaneously. In the case of Ehlers-Danlos syndrome type 7A, NGS genetic testing can be used to identify mutations or variations in the COL1A1 gene that may be responsible for the condition.

By identifying these genetic changes, NGS testing can help confirm a diagnosis of Ehlers-Danlos syndrome type 7A and provide important information for genetic counseling, treatment planning, and management of the condition. It can also be used for carrier testing and prenatal diagnosis in families with a known COL1A1 gene mutation.